Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research  (CIHR)
Not yet recruiting - verified June 2015

Venous Thromboembolic Complications in Ovarian Cancer

Conditions:   Venous Thromboembolism;   Ovarian Neoplasms;   Ovarian Cancer;   Deep Vein Thrombosis;   Lung Embolism
Intervention:  
Sponsor:   Aalborg Universitetshospital  
Recruiting - verified May 2015

Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

Condition:   Deep Venous Thrombosis
Intervention:   Drug: Rivaroxaban
Sponsor:   Ostfold Hospital Trust
Recruiting - verified June 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Surgical Tourniquets and Cerebral Emboli

Conditions:   Osteoarthritis;   RA;   Trauma
Intervention:  
Sponsor:   University Hospitals Coventry and Warwickshire NHS Trust
Completed - verified June 2015

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Conditions:   Deep Vein Thrombosis;   Blood Clots
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified June 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified June 2015

Prehospital Tranexamic Acid Use for Traumatic Brain Injury

Condition:   Traumatic Brain Injury
Interventions:   Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI);   U.S. Army Medical Research and Materiel Command;   Canadian Institutes of Health Research  (CIHR);   Heart and Stroke Foundation of Canada;   American Heart Association;   Defence Research and Development Canada
Recruiting - verified June 2015

Compression in Anklefracture Treatment, The CAT-study

Condition:   Ankle Fractures
Interventions:   Device: Flowtron Hydroven and Coban2 Lite;   Other: Braun frame;   Device: compression bandage
Sponsors:   Hillerod Hospital, Denmark;   The Research Unit, Northzealand Hospital;   Unit of Orthopedic Surgery, Northzealand Hospital
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified June 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified June 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified April 2015

Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis

Condition:   Thrombosis
Intervention:   Other: No intervention
Sponsor:   University Hospital, Basel, Switzerland
Recruiting - verified June 2015

The Diagnosis of Occult Deep Vein Thrombosis of the Lower Extremities in Patients Presenting With Hypoxia

Condition:   Hypoxia
Intervention:   Device: Ultrasound compression of femoral and popliteal veins
Sponsor:   HaEmek Medical Center, Israel
Completed - verified June 2015

Venous Thromboembolism in Advanced Gastric Cancer Patients

Condition:   Advanced Gastric Cancer
Intervention:  
Sponsor:   Asan Medical Center
Completed - verified June 2015

Get CardioSmart

You're Invited